Dolby Laboratories (NYSE:DLB) Releases Q1 2025 Earnings Guidance

Dolby Laboratories (NYSE:DLB) updated its first quarter 2025 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 0.960-1.110 for the period, compared to the consensus estimate of 0.700. The company issued revenue guidance of $330.0 million-$360.0 million, compared to the consensus revenue estimate of $307.9 million. Dolby Laboratories also updated its FY 2025 guidance to 3.990-4.140 EPS.

Dolby Laboratories Price Performance

DLB stock traded down $0.42 during trading on Tuesday, reaching $70.93. The company had a trading volume of 416,799 shares, compared to its average volume of 396,175. Dolby Laboratories has a 52 week low of $66.35 and a 52 week high of $90.06. The company has a market cap of $6.76 billion, a P/E ratio of 32.38 and a beta of 0.98. The business has a 50 day moving average of $73.66 and a 200 day moving average of $76.09.

Dolby Laboratories declared that its board has initiated a share buyback program on Wednesday, August 7th that authorizes the company to repurchase $350.00 million in shares. This repurchase authorization authorizes the electronics maker to repurchase up to 5% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company’s board of directors believes its shares are undervalued.

Wall Street Analyst Weigh In

DLB has been the subject of a number of research reports. Barrington Research reissued an “outperform” rating and issued a $100.00 price target on shares of Dolby Laboratories in a research note on Friday, September 20th. StockNews.com raised shares of Dolby Laboratories from a “buy” rating to a “strong-buy” rating in a research note on Monday.

Insider Buying and Selling at Dolby Laboratories

In other Dolby Laboratories news, CEO Kevin J. Yeaman sold 28,512 shares of the firm’s stock in a transaction that occurred on Tuesday, October 15th. The shares were sold at an average price of $74.12, for a total transaction of $2,113,309.44. Following the completion of the transaction, the chief executive officer now owns 83,721 shares of the company’s stock, valued at approximately $6,205,400.52. This trade represents a 25.40 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 39.54% of the company’s stock.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.